Vical, Inc. (NASDAQ:VICL)

CAPS Rating: 4 out of 5

The Company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Recs

0
Player Avatar pchop123 (79.59) Submitted: 2/28/2013 11:03:53 AM : Underperform Start Price: $3.16 VICL Score: -24.70

downside still exceeds upside

Featured Broker Partners


Advertisement